Neuromyelitis optica spectrum disorders in children and adolescents
Neuromyelitis optica (NMO) is a severe autoimmune disease of the CNS characterized by recurrent inflammatory events primarily involving the optic nerves and spinal cord. NMO is infrequent in children, but early recognition is important to start adequate treatment. In this article, we review the evolving diagnostic criteria of NMO and provide an update on the clinical and neuroimaging spectrum of the disorder in pediatric patients, including current knowledge on immunopathogenesis and treatment recommendations for children with NMO..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:87 |
|---|---|
| Enthalten in: |
Neurology - 87(2016), 9_Supplement_2 Suppl 1, Seite S59-S66 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tenembaum, Silvia [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: |
|---|
| RVK: |
|---|
| doi: |
10.1212/WNL.0000000000002824 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1982074221 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1982074221 | ||
| 003 | DE-627 | ||
| 005 | 20230517213254.0 | ||
| 007 | tu | ||
| 008 | 161013s2016 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1212/WNL.0000000000002824 |2 doi | |
| 028 | 5 | 2 | |a PQ20161012 |
| 035 | |a (DE-627)OLC1982074221 | ||
| 035 | |a (DE-599)GBVOLC1982074221 | ||
| 035 | |a (PRQ)c1130-9c3f2474adb3515171ce8c2a41a1d5e3745c0bab9a678e296811bf48de7155950 | ||
| 035 | |a (KEY)0070612420160000087000900059neuromyelitisopticaspectrumdisordersinchildrenanda | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a XA 10000 |q AVZ |2 rvk | ||
| 084 | |a 44.90 |2 bkl | ||
| 100 | 1 | |a Tenembaum, Silvia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neuromyelitis optica spectrum disorders in children and adolescents |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Neuromyelitis optica (NMO) is a severe autoimmune disease of the CNS characterized by recurrent inflammatory events primarily involving the optic nerves and spinal cord. NMO is infrequent in children, but early recognition is important to start adequate treatment. In this article, we review the evolving diagnostic criteria of NMO and provide an update on the clinical and neuroimaging spectrum of the disorder in pediatric patients, including current knowledge on immunopathogenesis and treatment recommendations for children with NMO. | ||
| 540 | |a Nutzungsrecht: © 2016 American Academy of Neurology | ||
| 540 | |a © 2016 American Academy of Neurology. | ||
| 700 | 1 | |a Chitnis, Tanuja |4 oth | |
| 700 | 1 | |a Nakashima, Ichiro |4 oth | |
| 700 | 1 | |a Collongues, Nicolas |4 oth | |
| 700 | 1 | |a McKeon, Andrew |4 oth | |
| 700 | 1 | |a Levy, Michael |4 oth | |
| 700 | 1 | |a Rostasy, Kevin |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Neurology |d Hagerstown, Md. : Lippincott Williams & Wilkins, 1951 |g 87(2016), 9_Supplement_2 Suppl 1, Seite S59-S66 |w (DE-627)129495174 |w (DE-600)207147-2 |w (DE-576)014893118 |x 0028-3878 |7 nnns |
| 773 | 1 | 8 | |g volume:87 |g year:2016 |g number:9_Supplement_2 Suppl 1 |g pages:S59-S66 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1212/WNL.0000000000002824 |3 Volltext |
| 856 | 4 | 2 | |u http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00006114-201608301-00010 |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/27572863 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_55 | ||
| 912 | |a GBV_ILN_2002 | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_2410 | ||
| 912 | |a GBV_ILN_2412 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | r | v | |a XA 10000 |
| 936 | b | k | |a 44.90 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 87 |j 2016 |e 9_Supplement_2 Suppl 1 |h S59-S66 | ||